The regulatory mechanisms of protein expression in heart failure patients' cardiomyocytes. The ubiquitin-proteasome system. Autophagy;Mechanizmy regulacji ekspresji białek w kardiomiocytach chorych z niewydolnościa̧ serca. System ubikwityna-proteasom. Autofagia

Kardiologia Polska

Volumn 70, Issue 11, 2012, Pages 1170-1176

  Pawlak, Agnieszka ^a   Bil, Jacek ^a   Gil, Robert J ^a,b  

^a CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; UBIQUITIN;

AUTOPHAGY; HEART FAILURE; HEART MUSCLE CELL; HUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW;

EID: 84870038740     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Ciechanover A. The ubiquitin proteolytic system: from an idea to the patient bed. Proc Am Thorac Soc, 2006; 3: 21-31.
2. Schubert U, Antón LC, Gibbs J et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature, 2000; 404: 770-774. (Pubitemid 30212405)
3. Powell SR. The ubiquitin - proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol, 2006; 291: H1-H19.
4. Ciechanover A. The ubiquitin proteolitic system: from a vague idea, through basic mechanisms and onto human diseases and drug targeting. Neurology, 2006; 66: S7-S19. (Pubitemid 43739979)
5. Bury M., Niemierko A. Proteasomalna degradacja białek komórkowych. Postȩpy Biol Kom, 2005; 32: 435-448.
6. Mukhopadhyay D, Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science, 2007; 315: 201-205. (Pubitemid 46166358)
7. Herrmann J, Ciechanover A, Lerman LO, Lerman A. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. Cardiovasc Res, 2004; 61: 11-21. (Pubitemid 38056676)
8. Jurczyszyn A, Skotnicki AB. Proteasome inhibition as a novel terapeutic target in neoplasmatic disease. Adv Clin Exp Med, 2006; 15: 309-320. (Pubitemid 43833951)
9. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature, 2003; 426: 895-899. (Pubitemid 38056882)
10. Beardslee MA, Laing JG, Beyer EC, Saffitz JE. Rapid turnover of connexin43 in the adult rat heart. Circ Res, 1998; 83: 629-635. (Pubitemid 28427746)
11. Purcell NH, Tang G, Yu C et al. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci USA, 2001; 98: 6668-6673. (Pubitemid 32538274)
12. Willis MS, Schisler JC, Portbury AL, Patterson C. Build it up-Tear it down: protein quality control in the cardiac sarcomere. Cardiovasc Res, 2009; 81: 439-448.
13. Eble DM, Spragia ML, Ferguson AG, Samarel AM. Sarcomeric myosin heavy chain is degraded by the proteasome. Cell Tissue Res, 1999; 296: 541-548. (Pubitemid 29253685)
14. Pawlak A, Czarnowska E, Pronicki M et al. Expression of ubiquitin in patient with heart failure depending on desmin expression. Eur J Heart Fail, 2010; 9: S1.
15. Pawlak A, Gil RJ, Kasprzak J et al. Cardiomyocyte desmin abnormalities - an accurate predictor of long-term survival in patients with chronic heart failure. Kardiol Pol, 2009; 67: 724-733.
16. Pawlak A, Gil RJ, Walczak E, Seweryniak P. Desmin expression in human cardiomyocytes and selected clinical and echocardiographic parameters in patients with chronic heart failure. Kardiol Pol, 2009; 67: 955-961.
17. Liu J, Tang M, Mestril R, Wang X. Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. J Mol Cell Cardiol, 2006; 40: 451-454.
18. Su H, Wang X. The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. Cardiovasc Res, 2010; 85: 253-262.
19. Chen Q, Liu JB, Horak KM et al. Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ Res, 2005; 97: 1018-1026. (Pubitemid 41668915)
20. Sarikas A, Carrier L, Schenke C et al. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res, 2005; 66: 33-44. (Pubitemid 40357866)
21. Ishii T, Sakurai T, Usami H, Uchida K. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome. Biochemistry, 2005; 44: 13893-13901. (Pubitemid 41507469)
22. Toth A, Nickson P, Qin LL, Erhardt P. Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J Biol Chem, 2006; 281: 3679-3689. (Pubitemid 43845986)
23. den Engelsman J, Keijsers V, de Jong WW, Boelens WC. The small heat-shock protein alpha B-crystallin promotes FBX4-dependent ubiquitination. J Biol Chem, 2003; 278: 4699-4704. (Pubitemid 36800969)
24. Pye J, Ardeshirpour F, McCain A et al. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol, 2003; 284: H919-H926. (Pubitemid 36228240)
25. Hedhli N, Lizano P, Hong C et al. Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. Am J Physiol Heart Circ Physiol, 2008; 295: H1385-H1393.
26. Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differ, 2005; 12 (suppl. 2): 1528-1534. (Pubitemid 41553989)
27. Eisenberg-Lerner A, Kimchi A. The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis, 2009; 14: 376-391.
28. Mizushima N, Kuma A, Kobayashi Y et al. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J Cell Sci, 2003; 116 (Part 9):1679-1688. (Pubitemid 36582155)
29. Klionsky DJ, Abeliovich H, Agostinis P et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy, 2008; 4: 151-175.
30. Mizushima N, Klionsky DJ. Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr, 2007; 27: 19-40. (Pubitemid 351373346)
31. Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol, 2004; 14: 70-77. (Pubitemid 38186640)
32. Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol, 1990; 181:195-213. (Pubitemid 20153523)
33. Ertmer A, Huber V, Gilch S et al. The anticancer drug imatinib induces cellular autophagy. Leukemia, 2007; 21: 936-942. (Pubitemid 46672069)
34. Bil J, Winiarska M, Nowis D et al. Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity. Blood, 2010; 115: 3745-3755.
35. Nishida K, Kyoi S, Yamaguchi O et al. The role of autophagy in the heart. Cell Death Differ, 2009; 16: 31-38.
36. Matsui Y, Takagi H, Qu X et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100: 914-922. (Pubitemid 46555697)
37. Tannous P, Zhu H, Nemchenko A et al. Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation, 2008; 117: 3070-3078.
38. Nakai A, Yamaguchi O, Takeda T H et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med, 2007; 13: 619-624. (Pubitemid 46828485)
39. Kassiotis C, Ballal K, Wellnitz K et al. Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation, 2009; 120 (11 suppl.): S191-S197.
40. Tanaka Y, Guhde G, Suter A et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature, 2000; 406: 902-906. (Pubitemid 30664267)
41. Nemchenko A, Chiong M, Turer A et al. Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol, 2011; 51: 584-593.
42. Maron BJ, Roberts WC, Arad M et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA, 2009; 301: 1253-1259.
43. Yan L, Vatner DE, Kim SJ et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA, 2005; 102: 13807-13812. (Pubitemid 41377660)
44. Aranguiz-Urroz P, Canales J, Copaja M et al. Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. Biochim Biophys Acta, 2011; 1812: 23-31.
45. Sasaki H, Asanuma H, Fujita M et al. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation, 2009; 119: 2568-2577.
46. Gimenez-Xavier P, Francisco R, Santidrian AF et al. Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model. Neurotoxicology, 2009; 30: 658-665.
47. Huang C, Liu W, Perry CN et al. Autophagy and protein kinase C are required for cardioprotection by sulfaphenazole. Am J Physiol Heart Circ Physiol, 2010; 298: H570-H579.
48. Sala-Mercado JA, Wider J, Undyala VV et al. Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation, 2010; 122 (11 suppl.): S179-S184.
49. Martinet W, Verheye S, De Meyer GR. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy. Autophagy, 2007; 3: 241-244. (Pubitemid 46752686)
50. Buss SJ, Muenz S, Riffel JH et al. Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol, 2009, 54: 2435-2446.